ArticleCureus2026
Prevalence and Causes of Visual Impairment and Blindness in the Qassim Region, Saudi Arabia: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVisual impairment (VI) and blindness occur when processes and structures responsible for vision are malfunctioning or damaged. Neglect, inappropriate handling, and delayed treatment of this condition could lead to adverse visual health outcomes. Understanding the prevalence and causes of this condition will enhance preventative measures and ultimately reduce the number of occurrences.
methodsThe study was a retrospective cohort study that interrogated 385 medical records of patients of various age groups who attended outpatient eye clinics at Qassim University Medical City (QUMC) between January 2023 and December 2024. Data was first cleaned and then analyzed using IBM SPSS Statistics for Windows, Version 27 (Released 2019; IBM Corp., Armonk, New York, United States) to obtain crucial insights.
resultsThe study found approximately 58.2% prevalence of VI and blindness among the patients. Most patients had moderate VI (123, 54.9%), followed by mild (70, 31.3%), severe (27, 12.1%), and blindness (4, 1.8%). The leading causes were refractive error (125, 32.5%) and cataract (80, 20.8%). Statistically significant associations were found between patients' nationality, presenting visual acuity (VA), systemic comorbidities, intervention, and the prevalence of VI and blindness (p=0.030, p<0.001, p<0.001, p=0.005). Intervention received by patients was positively associated with VI and blindness (AOR=3.40; 95% CI=1.219-9.498; p=0.019). Additionally, age (AOR=1.05; 95% CI=1.035-1.065; p<0.001) and presenting VA (AOR=0.42; 95% CI=0.231-0.756; p=0.004) were significantly associated with VI and blindness.
conclusionVI cases are prevalent among patients attending eye clinics at QUMC, presenting symptoms like decreased vision and blurred vision. The leading causes were refractive error and cataract, with most patients presenting moderate and mild VI. The most common comorbidities were diabetes mellitus and hypertension. There is a need for patients to take prompt action and preventive measures, including regular eye examinations, to minimize the incidence of VI and the risk of blindness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.